MMX Mesalamine Induces Remission Of Ulcerative Colitis

... A novel formulation of Multi-Matrix SystemTM (MMX) mesalamine (MesavanceTM) induces remission in patients with active mild-to- moderate ulcerative colitis and is generally well-tolerated at once-daily and twice-daily dosing, researchers announced at the here at Digestive Disease Week (DDW). [click link for full article] ...